House passes bill to enhance health care tax benefits - KPMG United States
Share with your friends

Legislative update: House passes bill to enhance health care tax benefits

House passes bill to enhance health care tax benefits

The U.S. House of Representatives today, by a vote of 243 to 164, passed H.R. 1270, the Restoring Access to Medication Act of 2015.


Related content

Read text [PDF 45 KB] of the bill. Read a revenue estimate of H.R. 1270, prepared by the Joint Committee on Taxation. The bill’s $20.5 billion revenue cost would be offset by repealing a provision of the Affordable Care Act that limits the liability for overpayment of advance payments for premium assistance for persons with household income below 400% of the federal poverty level. 

The bill passed by the House combines three smaller bills—each of which previously had been approved by the Ways and Means Committee:

  • A bill that would make certain over-the-counter drugs eligible for reimbursement through health flexible spending arrangements (FSAs), health reimbursement arrangements (HSAs) and Archer medical savings accounts (Archer MSAs), effective for expenses incurred after December 31, 2016
  • A bill to modify the rules governing HSAs, including measures to increase the contribution limit, allow two spouses to make catch-up contributions to the same account, and allow certain expenses incurred prior to opening an account to be reimbursed by the account, effective for tax years and coverage beginning after December 31, 2016
  • A bill that would require individuals who receive “Obamacare” exchange subsidies that they were not entitled to receive by reason of underreported income to repay the full amount of overpayments to the Treasury

The Senate has not yet scheduled action on the bill, and it is unclear whether the Senate will act on the legislation this year.

© 2019 KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved.

KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.

The KPMG logo and name are trademarks of KPMG International. KPMG International is a Swiss cooperative that serves as a coordinating entity for a network of independent member firms. KPMG International provides no audit or other client services. Such services are provided solely by member firms in their respective geographic areas. KPMG International and its member firms are legally distinct and separate entities. They are not and nothing contained herein shall be construed to place these entities in the relationship of parents, subsidiaries, agents, partners, or joint venturers. No member firm has any authority (actual, apparent, implied or otherwise) to obligate or bind KPMG International or any member firm in any manner whatsoever. The information contained in herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us


Want to do business with KPMG?


Request for proposal